Dr. Stephen J. Chanock, director of NCI’s Division of Cancer Epidemiology and Genetics, will present “The Complexity of Genetic Susceptibility to Cancer,” the 11th Jeffrey M. Trent Lecture in Cancer Research, on Wednesday, Feb. 11 at 1 p.m. in Masur Auditorium, Bldg. 10. The talk is sponsored by the National Human Genome Research Institute.
Chanock, a leading expert in the discovery and characterization of cancer susceptibility regions in the human genome, has received numerous awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes.
He received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases and pediatric hematology/oncology and research training in molecular genetics at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. Since 1995, Chanock has served as medical director for Camp Fantastic, a recreational camp for pediatric cancer patients, which is a joint venture of NCI and Special Love, Inc.
From 2001-2007, he was a tenured investigator in the genomic variation section of the Pediatric Oncology Branch in the NCI Center for Cancer Research. He also served as co-chair of NCI’s Genetics, Genomics and Proteomics Faculty for 5 years. In 2001, he was appointed chief of the Cancer Genomics Research Laboratory (formerly Core Genotyping Facility) and in 2007, chief of the Laboratory of Translational Genomics, both within the NCI Division of Cancer Epidemiology and Genetics. Chanock co-led the Cancer Genetic Markers of Susceptibility project. From 2012 to 2013, he also served as acting co-director of the NCI Center for Cancer Genomics. He was appointed DCEG director in August 2013.
Trent was NHGRI founding scientific director, serving in this role for more than 9 years. His leadership and vision were instrumental in establishing NHGRI’s Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics. In recognition of his significant contributions to the research environment at NIH, NHGRI established the annual Trent lectureship in 2003. The talk is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Trent has exemplified throughout his career.
Sign language interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this event should contact Nora Miralieva, email@example.com or (301) 443-4404.